Regulatory Artwork Services

An American multinational pharmaceutical company had engaged Freyr to facilitate a swift MAH transfer process following its acquisition of an Indian company. Faced with the challenge of updating over 1000 artworks across 40+ countries within a tight timeframe, the company had turned to Freyr for end-to-end support. Freyr's comprehensive approach ensured 100% quality and timely delivery.

A prominent US-based multinational biopharmaceutical company needed artwork support in diverse languages for biologics and new molecular entities in various therapeutic areas. They had collaborated with Freyr, who provided comprehensive artwork services supporting operations across North America, Europe, APAC, and other regions. Freyr ensured 100% quality for client satisfaction and maintained 100% TAT for timely delivery, fostering client trust.

The client, a US-based pharmaceutical manufacturer, had needed to update over 1500 injectable product artworks within a stringent two-month deadline, amidst an Adobe update and other Regulatory challenges. They turned to Freyr for comprehensive support. Freyr had meticulously overcome technical challenges and ensured compliance, delivering seamless and error-free artwork updates on time with 100% quality.

A Danish specialty pharmaceutical company needed quality, compliance, and efficiency in artwork operations across 35 countries. Faced with multiple submissions and the need for artwork operations support, they had turned to Freyr. Freyr had delivered end-to-end services, ensured 100% quality, and streamlined project execution. This comprehensive support met the client's diverse needs, ensuring Regulatory compliance and operational efficiency.

A leading Canada-based pharmaceutical company had sought to transition to a consolidated outsourcing model to support artwork transitions for generic products across Canada, Mexico, Australia, and India. They had turned to Freyr for comprehensive end-to-end services. Freyr's support facilitated a seamless transition, resulting in zero artwork recalls and over USD 300K in cost savings within seven months.

An American multinational pharmaceutical company had engaged Freyr to facilitate a swift MAH transfer process following its acquisition of an Indian company. Faced with the challenge of updating over 1000 artworks across 40+ countries within a tight timeframe, the company had turned to Freyr for end-to-end support. Freyr's comprehensive approach ensured 100% quality and timely delivery.